Verition Fund Management LLC Biomarin Pharmaceutical Inc Transaction History

Verition Fund Management LLC

  • $21.7 Billion
  • Q3 2025

A detailed history of Verition Fund Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 156,745 shares of BMRN stock, worth $8.58 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
156,745
Previous 291,478 46.22%
Holding current value
$8.58 Million
Previous $16 Million 47.02%
% of portfolio
0.04%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$52.62 - $61.93 $7.09 Million - $8.34 Million
-134,733 Reduced 46.22%
156,745 $8.49 Million
Q2 2025

Aug 14, 2025
BUY
$54.08 - $68.32 $9.94 Million - $12.6 Million
183,821 Added 170.75%
291,478 $16 Million
Q1 2025

May 15, 2025
BUY
$61.25 - $72.83 $2.76 Million - $3.28 Million
45,079 Added 72.04%
107,657 $7.61 Million
Q4 2024

Feb 14, 2025
BUY
$61.93 - $70.49 $698,632 - $795,197
11,281 Added 21.99%
62,578 $4.11 Million
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $1.5 Million - $2.03 Million
-21,680 Reduced 29.71%
51,297 $3.61 Million
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $268,320 - $332,453
3,605 Added 5.2%
72,977 $6.01 Million
Q1 2024

May 14, 2024
BUY
$83.81 - $99.0 $144,069 - $170,181
1,719 Added 2.54%
69,372 $6.06 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $112,576 - $145,499
1,477 Added 2.23%
67,653 $6.52 Million
Q3 2023

Nov 14, 2023
SELL
$85.07 - $94.48 $435,728 - $483,926
-5,122 Reduced 7.18%
66,176 $5.86 Million
Q2 2023

Aug 14, 2023
SELL
$86.68 - $100.3 $5.59 Million - $6.47 Million
-64,519 Reduced 47.5%
71,298 $6.18 Million
Q1 2023

May 15, 2023
SELL
$87.74 - $117.27 $5.7 Million - $7.62 Million
-65,018 Reduced 32.37%
135,817 $13.2 Million
Q4 2022

Feb 14, 2023
SELL
$80.93 - $108.63 $3.87 Million - $5.2 Million
-47,834 Reduced 19.24%
200,835 $20.8 Million
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $1.42 Million - $1.68 Million
-17,306 Reduced 6.51%
248,669 $21.1 Million
Q2 2022

Aug 15, 2022
BUY
$71.48 - $86.85 $5.39 Million - $6.55 Million
75,450 Added 39.6%
265,975 $22 Million
Q1 2022

May 13, 2022
BUY
$74.28 - $92.69 $9.36 Million - $11.7 Million
126,039 Added 195.45%
190,525 $14.7 Million
Q4 2021

Feb 14, 2022
SELL
$71.72 - $91.47 $21,085 - $26,892
-294 Reduced 0.45%
64,486 $5.7 Million
Q3 2021

Nov 15, 2021
SELL
$74.77 - $85.47 $7,626 - $8,717
-102 Reduced 0.16%
64,780 $5.01 Million
Q2 2021

Aug 16, 2021
SELL
$75.51 - $84.79 $5.26 Million - $5.91 Million
-69,703 Reduced 51.79%
64,882 $5.41 Million
Q4 2020

Feb 16, 2021
SELL
$72.61 - $90.2 $3.25 Million - $4.04 Million
-44,738 Reduced 24.95%
134,585 $11.8 Million
Q3 2020

Nov 16, 2020
BUY
$71.87 - $131.03 $5.68 Million - $10.4 Million
79,015 Added 78.77%
179,323 $13.6 Million
Q1 2020

May 15, 2020
BUY
$71.37 - $96.85 $306,034 - $415,292
4,288 Added 4.47%
100,308 $8.48 Million
Q4 2019

Feb 14, 2020
BUY
$64.27 - $86.37 $5.12 Million - $6.88 Million
79,615 Added 485.31%
96,020 $8.12 Million
Q3 2019

Nov 14, 2019
SELL
$67.4 - $85.11 $346,233 - $437,210
-5,137 Reduced 23.85%
16,405 $1.11 Million
Q2 2019

Aug 14, 2019
SELL
$80.35 - $93.9 $1.14 Million - $1.33 Million
-14,197 Reduced 39.72%
21,542 $1.85 Million
Q1 2019

May 15, 2019
SELL
$84.2 - $98.62 $3.74 Million - $4.38 Million
-44,372 Reduced 55.39%
35,739 $3.17 Million
Q4 2018

Feb 14, 2019
BUY
$80.14 - $106.07 $6.25 Million - $8.27 Million
77,983 Added 3664.61%
80,111 $6.82 Million
Q3 2018

Nov 15, 2018
BUY
$93.92 - $105.72 $199,861 - $224,972
2,128 New
2,128 $206,000
Q4 2017

Feb 15, 2018
SELL
$80.76 - $95.13 $829,566 - $977,175
-10,272 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$80.6 - $94.95 $827,923 - $975,326
10,272
10,272 $956,000

Others Institutions Holding BMRN

# of Institutions
667
Shares Held
182M
Call Options Held
1.48M
Put Options Held
957K
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email